Hans-Georg Kopp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hans-Georg Kopp has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Lothar Kanz
Department of Hematology, Oncology, Immunology, Rheumatology, Pulmonology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, 72076, Tuebingen, Germany
4 shared publications - Falko Fend
Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany
2 shared publications Frank Mayer
2 shared publicationsFrank Mayer
Department of Medical Oncology, Hematology, Immunology, Rheumatology and Pulmonology, Eberhard-Karls-University, Tuebingen, Germany
2 shared publicationsL. Kanz
Medizinische Klinik, Universitätsklinikum Tübingen
2 shared publications- Marius Horger
Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Tübingen, Germany
2 shared publications
Latest Publications
- 1 October 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 107, 175-182
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin
- 1 October 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 107, 175-182
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin
- Open Access
- 9 August 2016
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 619
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients
- 9 August 2016
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 619
Open AccessEfficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients
- Open Access
- 16 December 2015
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-5
Choroidal metastases from thymic carcinoma during pregnancy: Case Report
Rare sites of metastases, atypical symptoms and paraneoplastic syndromes are often neglected or misinterpreted, especially when they represent early symptoms of an underlying malignant disease. Hence, an interdisciplinary approach to these patients is essential to avoid tumor progression and metastatic spread in order to provide curative treatment options to the patients. We here report the case of a young woman presenting with visual loss which led to diagnosis of a thymic carcinoma. A 28-year old white woman presented with subacute loss of vision in the last trimester of her first pregnancy which was first interpreted as an exacerbation of a pre-existing dermatomyositis and treated with steroids. After failure of steroid therapy choroidal metastases from an undifferentiated thymic carcinoma were diagnosed. This also shed a new light on the dermatomyositis the patient had been suffering from for seven years possibly representing a paraneoplastic syndrome from the tumor. Despite aggressive chemotherapy, the patient died from progressive disease eight years after first onset of dermatomyositis and 14 months after initial diagnosis of the thymic carcinoma. Choroidal metastases from a thymic carcinoma have never been reported before but should be included into the differential diagnosis of choroidal masses.
- 16 December 2015
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-5
Open AccessChoroidal metastases from thymic carcinoma during pregnancy: Case Report
Rare sites of metastases, atypical symptoms and paraneoplastic syndromes are often neglected or misinterpreted, especially when they represent early symptoms of an underlying malignant disease. Hence, an interdisciplinary approach to these patients is essential to avoid tumor progression and metastatic spread in order to provide curative treatment options to the patients. We here report the case of a young woman presenting with visual loss which led to diagnosis of a thymic carcinoma. A 28-year old white woman presented with subacute loss of vision in the last trimester of her first pregnancy which was first interpreted as an exacerbation of a pre-existing dermatomyositis and treated with steroids. After failure of steroid therapy choroidal metastases from an undifferentiated thymic carcinoma were diagnosed. This also shed a new light on the dermatomyositis the patient had been suffering from for seven years possibly representing a paraneoplastic syndrome from the tumor. Despite aggressive chemotherapy, the patient died from progressive disease eight years after first onset of dermatomyositis and 14 months after initial diagnosis of the thymic carcinoma. Choroidal metastases from a thymic carcinoma have never been reported before but should be included into the differential diagnosis of choroidal masses.
- 1 April 2015
- Published by Elsevier in Academic Radiology
- Vol. 22 (4) , 505-512
Improved Detection of Bone Metastases from Lung Cancer in the Thoracic Cage using 5- and 1-mm Axial Images versus a New CT Software Generating Rib Unfolding Images
- 1 April 2015
- Published by Elsevier in Academic Radiology
- Vol. 22 (4) , 505-512
Improved Detection of Bone Metastases from Lung Cancer in the Thoracic Cage using 5- and 1-mm Axial Images versus a New CT Software Generating Rib Unfolding Images
- 16 March 2015
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 140 (06) , 426-427
Pulmonale Infektion bei Neutropenie – Fall 1/2015
Anamnese und klinischer Verlauf: Ein 42-jähriger Patient mit einer Haarzell-Leukämie war seit 3 Jahren bei einem niedergelassenen Hämatologen in ambulanter Behandlung. Nach Diagnosestellung wurde zunächst eine Therapie mit Cladribin eingeleitet, vor 6 Wochen wurde aufgrund eines Rezidivs die Therapie um Rituximab erweitert. Aktuell kam es zur Selbsteinweisung in die Notaufnahme mit Dyspnoe und Schmerzen beimAtmen. Untersuchungen, Therapie und Verlauf: Im Röntgen-Thorax fanden sich bipulmonale fleckige Infiltrate und Pleuraergüsse beidseits. Die anschließend durchgeführte Computertomographie (CT) zeigte beidseits Verdichtungen mit Halo-Zeichen, die als pilzverdächtig gewertet wurden. Mit der stationären Aufnahme erfolgte eine empirische antibiotische Therapie mit Clarithromycin und Piperacillin/Tazobactam, die im Verlauf auf Meropenem und Linezolid eskaliert wurde. Nach der CT wurde zusätzlich eine antimykotische Therapie zunächst mit Voriconazol begonnen und später auf liposomales Amphotericin B umgestellt. In der Mikrobiologie konnte initial ein positives Aspergillus-Antigen nachgewiesen werden. Unter Therapie war es dann mehrfach negativ. Bei Aufnahme fand sich eine ausgeprägte Trizytopenie, nach Umstellung der Therapie auf Vemurafenib und Filgrastim konnte die Leukopoese jedoch nur unzureichend stimuliert werden. Drei Tage nach Aufnahme wurde der Patient bei respiratorischer Insuffizienz auf die internistische Intensivsation verlegt, wo er am achten Tag starb. Obduktion und Diagnose: Es bestand ein Rezidiv einer Haarzell-Leukämie mit positiver BRAF-Mutation und einer Knochenmarkinfiltration von > 80 %. Bei der Obduktion fanden sich eine deutliche Hepato-Splenomegalie, eine fehlende Erythro-, Granulo- und Thrombopoese, mit Pilzhyphen durchsetzte Thromben in beiden Lungen und ein Infarktareal in der Milz mit Nachweis von Pilzhyphen. Der kulturelle Befund auf Spross- oder Schimmelpilze war post mortem negativ. Folgerung: Patienten mit refraktärer Haarzell-Leukämie und länger anhaltender Neutropenie haben ein deutlich erhöhtes Risiko für systemische Pilzinfektionen. Eine antimykotische Prophylaxe sollte daher frühzeitig eingeleitet werden. Der therapeutische Ansatz von Vemurafenib bei der therapierefraktären Haarzell-Leukämie ist vielversprechend und bietet im Rezidiv eine weitere Remissionsmöglichkeit. Im aktuellen Fall konnte der Patient durch die septischen Komplikationen leider nicht stabilisiert werden. Medical history and clinical course: A 42-year-old patient with hairy cell leukemia had been treated for 3 years by a hematologist in private practice. Initially the patient received 1 course of cladribine upon which the disease went into complete remission. 6 weeks ago a relapse was diagnosed and combination therapy with cladibrin and rituximab was initiated. Now the patient presented to the emergency room with shortness of breath and pain when breathing. Investigations, treatment and course: In the chest x-ray, patchy infiltrates and pleural effusions were found on both sides. The subsequently performed computed tomography showed bilateral compactions with an Halo suspicious for fungal infiltrates. Upon admission to the hospital, an empirical antibiotic therapy with clarithromycin and piperacillin/tazobactam was initiated, which was later escalated to meropenem and linezolid. Additionally, an antifungal therapy with voriconazole was started and later switched to liposomal amphotericin B. At his admission, a positive aspergillus antigen could be detected in the microbiological laboratory. Under antimycotic treatment the aspergillus antigen was repeatedly negative. The patient presented with pronounced cytopenias and after a switch of therapy to vemurafenib and filgrastim, the hematopoiesis could only be stimulated insufficiently. The patient was transferred to the intensive care unit three days after admission with severe respiratory failure. He died on day 8 after admission. Autopsy and diagnosis: Diagnosis was consistent with relapse of hairy cell leukemia with positive BRAF mutation and a bone marrow infiltration > 80 %. Autopsy revealed a significant hepato-splenomegaly, a lack of erythro-, granulo- and thrombopoiesis. Clots interspersed with fungal hyphae were found in both lungs and an infarction of the spleen with evidence of fungal hyphae was detected. The cultural findings post mortem on yeast or mold were negative. Conclusion: Patients with refractory hairy cell leukemia and prolonged neutropenia are at increased risk for systemic fungal infections. Therefore, prohylactic antimycotic therapy should be considered early in this group of patients. The therapeutic approach of vemurafenib in treatment-refractory hairy cell leukemia is promising and offers an additional treatment option. In the present case, the patient could unfortunately not be stabilized due to the septic complications.
- 16 March 2015
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 140 (06) , 426-427
Pulmonale Infektion bei Neutropenie – Fall 1/2015
Anamnese und klinischer Verlauf: Ein 42-jähriger Patient mit einer Haarzell-Leukämie war seit 3 Jahren bei einem niedergelassenen Hämatologen in ambulanter Behandlung. Nach Diagnosestellung wurde zunächst eine Therapie mit Cladribin eingeleitet, vor 6 Wochen wurde aufgrund eines Rezidivs die Therapie um Rituximab erweitert. Aktuell kam es zur Selbsteinweisung in die Notaufnahme mit Dyspnoe und Schmerzen beimAtmen. Untersuchungen, Therapie und Verlauf: Im Röntgen-Thorax fanden sich bipulmonale fleckige Infiltrate und Pleuraergüsse beidseits. Die anschließend durchgeführte Computertomographie (CT) zeigte beidseits Verdichtungen mit Halo-Zeichen, die als pilzverdächtig gewertet wurden. Mit der stationären Aufnahme erfolgte eine empirische antibiotische Therapie mit Clarithromycin und Piperacillin/Tazobactam, die im Verlauf auf Meropenem und Linezolid eskaliert wurde. Nach der CT wurde zusätzlich eine antimykotische Therapie zunächst mit Voriconazol begonnen und später auf liposomales Amphotericin B umgestellt. In der Mikrobiologie konnte initial ein positives Aspergillus-Antigen nachgewiesen werden. Unter Therapie war es dann mehrfach negativ. Bei Aufnahme fand sich eine ausgeprägte Trizytopenie, nach Umstellung der Therapie auf Vemurafenib und Filgrastim konnte die Leukopoese jedoch nur unzureichend stimuliert werden. Drei Tage nach Aufnahme wurde der Patient bei respiratorischer Insuffizienz auf die internistische Intensivsation verlegt, wo er am achten Tag starb. Obduktion und Diagnose: Es bestand ein Rezidiv einer Haarzell-Leukämie mit positiver BRAF-Mutation und einer Knochenmarkinfiltration von > 80 %. Bei der Obduktion fanden sich eine deutliche Hepato-Splenomegalie, eine fehlende Erythro-, Granulo- und Thrombopoese, mit Pilzhyphen durchsetzte Thromben in beiden Lungen und ein Infarktareal in der Milz mit Nachweis von Pilzhyphen. Der kulturelle Befund auf Spross- oder Schimmelpilze war post mortem negativ. Folgerung: Patienten mit refraktärer Haarzell-Leukämie und länger anhaltender Neutropenie haben ein deutlich erhöhtes Risiko für systemische Pilzinfektionen. Eine antimykotische Prophylaxe sollte daher frühzeitig eingeleitet werden. Der therapeutische Ansatz von Vemurafenib bei der therapierefraktären Haarzell-Leukämie ist vielversprechend und bietet im Rezidiv eine weitere Remissionsmöglichkeit. Im aktuellen Fall konnte der Patient durch die septischen Komplikationen leider nicht stabilisiert werden. Medical history and clinical course: A 42-year-old patient with hairy cell leukemia had been treated for 3 years by a hematologist in private practice. Initially the patient received 1 course of cladribine upon which the disease went into complete remission. 6 weeks ago a relapse was diagnosed and combination therapy with cladibrin and rituximab was initiated. Now the patient presented to the emergency room with shortness of breath and pain when breathing. Investigations, treatment and course: In the chest x-ray, patchy infiltrates and pleural effusions were found on both sides. The subsequently performed computed tomography showed bilateral compactions with an Halo suspicious for fungal infiltrates. Upon admission to the hospital, an empirical antibiotic therapy with clarithromycin and piperacillin/tazobactam was initiated, which was later escalated to meropenem and linezolid. Additionally, an antifungal therapy with voriconazole was started and later switched to liposomal amphotericin B. At his admission, a positive aspergillus antigen could be detected in the microbiological laboratory. Under antimycotic treatment the aspergillus antigen was repeatedly negative. The patient presented with pronounced cytopenias and after a switch of therapy to vemurafenib and filgrastim, the hematopoiesis could only be stimulated insufficiently. The patient was transferred to the intensive care unit three days after admission with severe respiratory failure. He died on day 8 after admission. Autopsy and diagnosis: Diagnosis was consistent with relapse of hairy cell leukemia with positive BRAF mutation and a bone marrow infiltration > 80 %. Autopsy revealed a significant hepato-splenomegaly, a lack of erythro-, granulo- and thrombopoiesis. Clots interspersed with fungal hyphae were found in both lungs and an infarction of the spleen with evidence of fungal hyphae was detected. The cultural findings post mortem on yeast or mold were negative. Conclusion: Patients with refractory hairy cell leukemia and prolonged neutropenia are at increased risk for systemic fungal infections. Therefore, prohylactic antimycotic therapy should be considered early in this group of patients. The therapeutic approach of vemurafenib in treatment-refractory hairy cell leukemia is promising and offers an additional treatment option. In the present case, the patient could unfortunately not be stabilized due to the septic complications.
- Open Access
- 23 May 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 313
Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report
While paraneoplastic leukocytosis is a common phenomenon in solid tumors, extreme elevations of white blood counts (WBC) in the range of more than 100,000/μl are uncommon in patients with non-hematologic malignancies. Leukocytosis with mature neutrophils due to a granulocyte colony-stimulating factor (G-CSF) producing tumor is only seen on rare occasions.
- 23 May 2014
- Published by Springer Nature in BMC Research Notes
- Vol. 7 (1) , 313
Open AccessParaneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report
While paraneoplastic leukocytosis is a common phenomenon in solid tumors, extreme elevations of white blood counts (WBC) in the range of more than 100,000/μl are uncommon in patients with non-hematologic malignancies. Leukocytosis with mature neutrophils due to a granulocyte colony-stimulating factor (G-CSF) producing tumor is only seen on rare occasions.
- 1 March 2013
- Vol. 33 (3) , 791-800
Progesterone and estrogen prevent cisplatin-induced apoptosis of lung cancer cells.
Metastatic non-small cell lung cancer (NSCLC) remains the most common cause of tumor mortality despite the introduction of novel agents. Female sex hormones play a role in NSCLC pathogenesis and negatively influence the course of this disease. Herein, we present data on possible underlying mechanisms. Both estrogen and progesterone pre-treatment led to chemoresistance of A549 NSCLC cells in vitro by attenuating cisplatin-induced apoptosis. These effects were not antagonized by the estrogen or progesterone receptor antagonists ICI 182,780 and RU486 (mifepristone). Cisplatin induced apoptosis via activation of caspases -3/7, -8 and -9. Estrogen and progesterone attenuated levels of caspase activation. Interestingly, copper-transporter-1, which is responsible for the intracellular accumulation of cisplatin, was not modulated by sex hormones and the effects of estrogen and progesterone were neither additive nor synergistic. Our results suggest that estrogen and progesterone contribute to the development of chemotherapy resistance in NSCLC via non-classical sex hormone signaling pathways.
- 1 March 2013
- Vol. 33 (3) , 791-800
Progesterone and estrogen prevent cisplatin-induced apoptosis of lung cancer cells.
Metastatic non-small cell lung cancer (NSCLC) remains the most common cause of tumor mortality despite the introduction of novel agents. Female sex hormones play a role in NSCLC pathogenesis and negatively influence the course of this disease. Herein, we present data on possible underlying mechanisms. Both estrogen and progesterone pre-treatment led to chemoresistance of A549 NSCLC cells in vitro by attenuating cisplatin-induced apoptosis. These effects were not antagonized by the estrogen or progesterone receptor antagonists ICI 182,780 and RU486 (mifepristone). Cisplatin induced apoptosis via activation of caspases -3/7, -8 and -9. Estrogen and progesterone attenuated levels of caspase activation. Interestingly, copper-transporter-1, which is responsible for the intracellular accumulation of cisplatin, was not modulated by sex hormones and the effects of estrogen and progesterone were neither additive nor synergistic. Our results suggest that estrogen and progesterone contribute to the development of chemotherapy resistance in NSCLC via non-classical sex hormone signaling pathways.
- Open Access
- 1 March 2013
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (5) , 709-710
Steady-state neutrophil homeostasis is a demand-driven process
- 1 March 2013
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (5) , 709-710
Open AccessSteady-state neutrophil homeostasis is a demand-driven process
- Open Access
- 19 December 2012
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 2 (1) , 53-60
Shared Cell Surface Marker Expression in Mesenchymal Stem Cells and Adult Sarcomas
Advanced adult soft-tissue sarcomas (STSs) are rare tumors with a dismal prognosis and limited systemic treatment options. STSs may originate from mesenchymal stem cells (MSCs); the latter have mainly been isolated from adult bone marrow as plastic-adherent cells with differentiation capacity into mesenchymal tissues. Recently, a panel of antibodies has been established that allows for the prospective isolation of primary MSCs with high selectivity. Similar to cancer stem cells in other malignancies, sarcoma stem cells may bear immunophenotypic similarity with the corresponding precursor, that is, MSCs. We therefore set out to establish the expression pattern of MSC markers in sarcoma cell lines and primary tumor samples by flow cytometry. In addition, fibroblasts from different sources were examined. The results document a significant amount of MSC markers shared by sarcoma cells. The expression pattern includes uniformly expressed markers, as well as MSC markers that only stained subpopulations of sarcoma cells. Expression of W5C5, W8B2 (tissue nonspecific alkaline phosphatase [TNAP]), CD344 (frizzled-4), and CD271 marked subpopulations displaying increased proliferation potential. Moreover, CD271+ cells displayed in vitro doxorubicin resistance and an increased capacity to form spheres under serum-free conditions. Interestingly, another set of antigens, including the bona fide progenitor cell markers CD117 and CD133, were not expressed. Comparative expression patterns of novel MSC markers in sarcoma cells, as well as fibroblasts and MSCs, are presented. Our data suggest a hierarchical cytoarchitecture of the most common adult type sarcomas and introduce W5C5, TNAP, CD344, and CD271 as potential sarcoma progenitor cell markers.
- 19 December 2012
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 2 (1) , 53-60
Open AccessShared Cell Surface Marker Expression in Mesenchymal Stem Cells and Adult Sarcomas
Advanced adult soft-tissue sarcomas (STSs) are rare tumors with a dismal prognosis and limited systemic treatment options. STSs may originate from mesenchymal stem cells (MSCs); the latter have mainly been isolated from adult bone marrow as plastic-adherent cells with differentiation capacity into mesenchymal tissues. Recently, a panel of antibodies has been established that allows for the prospective isolation of primary MSCs with high selectivity. Similar to cancer stem cells in other malignancies, sarcoma stem cells may bear immunophenotypic similarity with the corresponding precursor, that is, MSCs. We therefore set out to establish the expression pattern of MSC markers in sarcoma cell lines and primary tumor samples by flow cytometry. In addition, fibroblasts from different sources were examined. The results document a significant amount of MSC markers shared by sarcoma cells. The expression pattern includes uniformly expressed markers, as well as MSC markers that only stained subpopulations of sarcoma cells. Expression of W5C5, W8B2 (tissue nonspecific alkaline phosphatase [TNAP]), CD344 (frizzled-4), and CD271 marked subpopulations displaying increased proliferation potential. Moreover, CD271+ cells displayed in vitro doxorubicin resistance and an increased capacity to form spheres under serum-free conditions. Interestingly, another set of antigens, including the bona fide progenitor cell markers CD117 and CD133, were not expressed. Comparative expression patterns of novel MSC markers in sarcoma cells, as well as fibroblasts and MSCs, are presented. Our data suggest a hierarchical cytoarchitecture of the most common adult type sarcomas and introduce W5C5, TNAP, CD344, and CD271 as potential sarcoma progenitor cell markers.
- 14 August 2012
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 137 (34/35) , 1705
Schwere Blutungen bei einer Patientin mit metastasierendem Kolonkarzinom - Fall 8/2012
Anamnese und klinischer Befund: Eine 65-jährige Patientin wurde mit massiver Hämatochezie, allgemeiner Blutungsneigung und Erstdiagnose eines Sigmakarzinoms zur weiteren Abklärung und Therapie übernommen. Untersuchungen: Es fanden sich Lebermetastasen sowie eine 90 %ige Knochenmarkinfiltration. Im peripheren Blut konnten ebenfalls wenige Tumorzellen gesichert werden. Rechtsseitige Unterbauchschmerzen konnten auf eine spontanes retroperitoneales Hämatom zurückgeführt werden (Abb. [ 1 ]). Diagnose, Therapie und Verlauf: Es bestanden eine mikroangiopathische Hämolyse sowie Hyperfibrinolyse mit massiver Blutungsneigung. Zudem zeigte sich ein akutes Nierenversagen, welches sich unter Infusionstherapie besserte. Die Gerinnung konnte unter rascher Einleitung einer palliativen Chemotherapie mit FOLFOX und Cetuximab stabilisiert werden. Die Therapie mittels Tranexamsäure, Fibrinogen, gefrorenem Frischplasma sowie Erythrozyten- und Thrombozytenkonzentraten konnte im Verlauf beendet werden. Unter einer antibiotischen Behandlung mit Tazobactam/Piperacillin zeigten sich auch die Entzündungsparameter rückläufig. Die Fortführung der Chemotherapie konnte unter guter Lebensqualität ambulant erfolgen. Die Patientin starb 7 Monate nach Erstdiagnose des Sigmakarzinoms bei Tumorprogress mit Hirnmetastasen. Folgerung: Eine disseminierte Aktivierung der Gerinnung, eine mikroangiopathische Hämolyse sowie sekundäre Hyperfibrinolyse können auch beim Kolonkarzinom auftreten. Vor allem eine Knochenmarkinfiltration kann dies begünstigen. Für eine Stabilisierung ist eine rasche Behandlung des Tumors mittels Chemotherapie notwendig. History and admission findings: We report on a 65-year-old female patient with a recent diagnosis of adenocarcinoma of the sigmoid colon and massive hematochezia in the context of a general bleeding disorder. Investigations: Disseminated malignant disease with hepatic metastases as well as bone marrow involvement was demonstrated. Moreover, circulating tumor cells were demonstrated by flow cytometry. The patient had right lower quadrant abdominal pain due to a spontaneous psoas intramuscular hematoma. Diagnosis, treatment and course: At the time of admission to our hospital, the patient displayed microangiopathic hemolytic anemia and secondary hyperfibrinolysis with a pronounced bleeding tendency. Moreover, there was an acute renal failure which improved with fluid resuscitation. With immediate chemotherapy consisting of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX regimen) and cetuximab initiated with the second course, plasmatic coagulation could be stabilized. Consequently, treatment with tranexamic acid, fibrinogen, fresh frozen plasma as well as red blood cell and platelet infusions could be stopped. Continuation of chemotherapy was possible on an outpatient basis and the further course was associated with a good quality of life until her near end. The patient died at home 7 months after initial diagnosis of her colon cancer due to progressive disease with CNS metastases. Conclusions: Disseminated intravascular coagulation with microangiopathic hemolysis and secondary hyperfibrinolysis is a rare albeit possible event in disseminated colorectal cancer, especially when the bone marrow is involved. Treatment of the underlying cause is the most important therapeutic measure.
- 14 August 2012
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 137 (34/35) , 1705
Schwere Blutungen bei einer Patientin mit metastasierendem Kolonkarzinom - Fall 8/2012
Anamnese und klinischer Befund: Eine 65-jährige Patientin wurde mit massiver Hämatochezie, allgemeiner Blutungsneigung und Erstdiagnose eines Sigmakarzinoms zur weiteren Abklärung und Therapie übernommen. Untersuchungen: Es fanden sich Lebermetastasen sowie eine 90 %ige Knochenmarkinfiltration. Im peripheren Blut konnten ebenfalls wenige Tumorzellen gesichert werden. Rechtsseitige Unterbauchschmerzen konnten auf eine spontanes retroperitoneales Hämatom zurückgeführt werden (Abb. [ 1 ]). Diagnose, Therapie und Verlauf: Es bestanden eine mikroangiopathische Hämolyse sowie Hyperfibrinolyse mit massiver Blutungsneigung. Zudem zeigte sich ein akutes Nierenversagen, welches sich unter Infusionstherapie besserte. Die Gerinnung konnte unter rascher Einleitung einer palliativen Chemotherapie mit FOLFOX und Cetuximab stabilisiert werden. Die Therapie mittels Tranexamsäure, Fibrinogen, gefrorenem Frischplasma sowie Erythrozyten- und Thrombozytenkonzentraten konnte im Verlauf beendet werden. Unter einer antibiotischen Behandlung mit Tazobactam/Piperacillin zeigten sich auch die Entzündungsparameter rückläufig. Die Fortführung der Chemotherapie konnte unter guter Lebensqualität ambulant erfolgen. Die Patientin starb 7 Monate nach Erstdiagnose des Sigmakarzinoms bei Tumorprogress mit Hirnmetastasen. Folgerung: Eine disseminierte Aktivierung der Gerinnung, eine mikroangiopathische Hämolyse sowie sekundäre Hyperfibrinolyse können auch beim Kolonkarzinom auftreten. Vor allem eine Knochenmarkinfiltration kann dies begünstigen. Für eine Stabilisierung ist eine rasche Behandlung des Tumors mittels Chemotherapie notwendig. History and admission findings: We report on a 65-year-old female patient with a recent diagnosis of adenocarcinoma of the sigmoid colon and massive hematochezia in the context of a general bleeding disorder. Investigations: Disseminated malignant disease with hepatic metastases as well as bone marrow involvement was demonstrated. Moreover, circulating tumor cells were demonstrated by flow cytometry. The patient had right lower quadrant abdominal pain due to a spontaneous psoas intramuscular hematoma. Diagnosis, treatment and course: At the time of admission to our hospital, the patient displayed microangiopathic hemolytic anemia and secondary hyperfibrinolysis with a pronounced bleeding tendency. Moreover, there was an acute renal failure which improved with fluid resuscitation. With immediate chemotherapy consisting of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX regimen) and cetuximab initiated with the second course, plasmatic coagulation could be stabilized. Consequently, treatment with tranexamic acid, fibrinogen, fresh frozen plasma as well as red blood cell and platelet infusions could be stopped. Continuation of chemotherapy was possible on an outpatient basis and the further course was associated with a good quality of life until her near end. The patient died at home 7 months after initial diagnosis of her colon cancer due to progressive disease with CNS metastases. Conclusions: Disseminated intravascular coagulation with microangiopathic hemolysis and secondary hyperfibrinolysis is a rare albeit possible event in disseminated colorectal cancer, especially when the bone marrow is involved. Treatment of the underlying cause is the most important therapeutic measure.